Doug Williams ups the ante at Codiak Bio to $168.5M in a drive to first human study
When Doug Williams exited his role as R&D chief at Biogen a couple of years ago to run his own startup, he made the leap …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
